We were the first to characterize the decidual-like CD56brightCD16− of NSCLC patients with the ability to release pro-angiogenic factors: VEGF, PlGF, and CXCL8 (Figure 1) (Table 1). Here, CXCL8 is linked to non-small cell lung carcinoma.